Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Psychiatric symptoms and COVID-19: results of a national case register].
van Dee V, Janssen EAM, Blom RM, Cahn W, van Mierlo HC, Mihaescu R, van Wullften Palthe J, Zijlstra R, Kok RM, Everaerd DS, Schellekens A, oviP-Consortium C. van Dee V, et al. Tijdschr Psychiatr. 2022;64(9):558-565. Tijdschr Psychiatr. 2022. PMID: 36349850 Free article. Dutch.
Correction: A genetic risk score to predict treatment nonresponse in psychotic depression.
Ter Hark SE, Coenen MJH, Vos CF, Aarnoutse RE, Nolen WA, Birkenhager TK, van den Broek WW, Schellekens AFA, Verkes RJ, Janzing JGE. Ter Hark SE, et al. Among authors: schellekens afa. Transl Psychiatry. 2024 Apr 26;14(1):198. doi: 10.1038/s41398-024-02912-0. Transl Psychiatry. 2024. PMID: 38671038 Free PMC article. No abstract available.
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients.
Knuijver T, Ter Heine R, Schellekens AFA, Heydari P, Lucas L, Westra S, Belgers M, van Oosteren T, Verkes RJ, Kramers C. Knuijver T, et al. Among authors: schellekens afa. J Psychopharmacol. 2024 May;38(5):481-488. doi: 10.1177/02698811241237873. Epub 2024 Mar 22. J Psychopharmacol. 2024. PMID: 38519421 Free PMC article.
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers CH, Kupka RW, Penninx BW, Ruhé HG, van Gaalen JM, van Haaren PCF, Schellekens AFA, Jauhar S, Ramos-Quiroga JA, Vieta E, Tiihonen J, Veldman SE, Veling W, Vis R, de Wit LE, Luykx JJ. Vinkers CH, et al. Among authors: schellekens afa. Mol Psychiatry. 2024 Mar 19. doi: 10.1038/s41380-024-02445-4. Online ahead of print. Mol Psychiatry. 2024. PMID: 38503923 Review.
A genetic risk score to predict treatment nonresponse in psychotic depression.
Ter Hark SE, Coenen MJH, Vos CF, Aarnoutse RE, Nolen WA, Birkenhager TK, van den Broek WW, Schellekens AFA, Verkes RJ, Janzing JGE. Ter Hark SE, et al. Among authors: schellekens afa. Transl Psychiatry. 2024 Mar 2;14(1):132. doi: 10.1038/s41398-024-02842-x. Transl Psychiatry. 2024. PMID: 38431658 Free PMC article. Clinical Trial.
Evaluating the Effectiveness of Take it Personal!+ in People With Mild Intellectual Disability or Borderline Intellectual Functioning and Substance Use Disorder: A Multiple Baseline Single-Case Experimental Study.
Gosens LCF, Poelen EAP, Didden R, de Jonge JM, Schellekens AFA, VanDerNagel JEL, Onghena P, Otten R. Gosens LCF, et al. Among authors: schellekens afa. Behav Ther. 2024 Mar;55(2):331-346. doi: 10.1016/j.beth.2023.07.007. Epub 2023 Jul 25. Behav Ther. 2024. PMID: 38418044 Free article. Clinical Trial.
'I am proud of how I handled it'. Exploring the impact of the COVID-19 pandemic and related restrictions on well-being of adults with severe mental illness using qualitative methods.
van Rijn L, Metz MJ, van der Velden PR, Mathijsen P, Swildens WE, Schellekens AFA, Cahn W, Milota MM, Zinkstok JR. van Rijn L, et al. Among authors: schellekens afa. Health Expect. 2024 Feb;27(1):e13983. doi: 10.1111/hex.13983. Health Expect. 2024. PMID: 38348759 Free PMC article.
89 results